CD22-CAR T cell immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD22-CAR T cell immunotherapy, covering 2025-06-17 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma [Phase 1]